- Home
- ANIP vs IVT Comparison
ANIP vs IVT Comparison
Compare ANIP & IVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- IVT
- Stock Information
- Founded
- ANIP 2001
- IVT 2005
- Country
- ANIP United States
- IVT United States
- Employees
- ANIP N/A
- IVT N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- IVT Real Estate Investment Trusts
- Sector
- ANIP Health Care
- IVT Real Estate
- Exchange
- ANIP Nasdaq
- IVT Nasdaq
- Market Cap
- ANIP 2.0B
- IVT 2.3B
- IPO Year
- ANIP N/A
- IVT N/A
- Fundamental
- Price
- ANIP $91.65
- IVT $27.55
- Analyst Decision
- ANIP Strong Buy
- IVT Buy
- Analyst Count
- ANIP 8
- IVT 5
- Target Price
- ANIP $93.63
- IVT $32.75
- AVG Volume (30 Days)
- ANIP 318.4K
- IVT 483.0K
- Earning Date
- ANIP 11-07-2025
- IVT 10-28-2025
- Dividend Yield
- ANIP N/A
- IVT 3.45%
- EPS Growth
- ANIP N/A
- IVT 1533.99
- EPS
- ANIP N/A
- IVT 1.47
- Revenue
- ANIP $747,399,000.00
- IVT $287,075,000.00
- Revenue This Year
- ANIP $39.36
- IVT $9.70
- Revenue Next Year
- ANIP $9.45
- IVT $8.25
- P/E Ratio
- ANIP N/A
- IVT $18.71
- Revenue Growth
- ANIP 38.68
- IVT 9.17
- 52 Week Low
- ANIP $52.50
- IVT $25.21
- 52 Week High
- ANIP $99.50
- IVT $31.65
- Technical
- Relative Strength Index (RSI)
- ANIP 46.26
- IVT 25.00
- Support Level
- ANIP $88.19
- IVT $29.27
- Resistance Level
- ANIP $92.52
- IVT $30.20
- Average True Range (ATR)
- ANIP 2.40
- IVT 0.40
- MACD
- ANIP -0.93
- IVT -0.25
- Stochastic Oscillator
- ANIP 26.50
- IVT 0.00
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About IVT InvenTrust Properties Corp.
InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.